冰点渗透仪研发商Advanced Instruments将收购Nova Biomedical并与之合并-动脉网

Patricia Industries' subsidiary Advanced Instruments to acquire and merge with Nova Biomedical

CISION 等信源发布 2025-03-19 19:15



可切换为仅中文







NORWOOD, Mass.

诺伍德，马萨诸塞州

，

March 19, 2025

2025年3月19日

/PRNewswire/ -- Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology therapeutics..

/PRNewswire/ -- Patricia Industries的子公司、为生物制药和临床市场生产分析仪器的Advanced Instruments今天宣布，已就收购Nova Biomedical达成最终协议。Nova Biomedical是一家创新型分析仪器和耗材制造商，其产品对指导患者治疗和生物技术疗法的开发至关重要。

Following the closing of the transaction, Advanced Instruments and Nova Biomedical will merge, creating a global life science tools platform that will operate under the Nova Biomedical name, with a diversified portfolio of analytical instruments, reagents and services.

交易完成后，Advanced Instruments 和 Nova Biomedical 将合并，创建一个全球生命科学工具平台，该平台将以 Nova Biomedical 的名义运营，拥有多样化的分析仪器、试剂和服务组合。

Byron Selman

拜伦·塞尔曼

, President & CEO of Advanced Instruments, will lead the combined business, while Nova Biomedical founding shareholders

，Advanced Instruments的总裁兼首席执行官，将领导合并后的业务，而Nova Biomedical的创始股东们

Frank Manganaro

弗兰克·曼加纳罗

, CEO and Dr.

，首席执行官和博士。

Chung-Chang Young

杨忠昌

, EVP of R&D, will stay with the company in a consulting capacity. For the full year 2024, the combined business generated sales of

研发执行副总裁将继续以顾问身份留在公司。2024年全年，合并后的业务创造了销售业绩

$621M

6.21亿美元

. Over the past 10 years, pro forma organic sales growth has averaged approximately 8 percent.

在过去十年中，模拟的有机销售增长平均约为8%。

'Combining these two great companies aligns with our core strategy to develop and commercialize best-in-class technologies that deliver significant customer value across the biopharma and clinical markets,' commented Mr. Selman. 'The combination of our technologies, R&D strength, global sales network, dedicated teams and commitment to innovation will advance our collective ability to support customer workflows within various stages of drug development and bioprocessing and expand our footprint within the hospital and other healthcare settings, guiding patient care with our diversified product portfolio and supporting our growing customer base.' .

“将这两家伟大的公司结合在一起，符合我们开发和商业化一流技术的核心战略，这些技术将在生物制药和临床市场为客户提供巨大的价值，”塞尔曼先生评论道。“我们的技术、研发实力、全球销售网络、专业团队以及对创新的承诺相结合，将提升我们支持药物开发和生物处理各阶段客户工作流程的整体能力，并扩大我们在医院及其他医疗环境中的影响力，通过我们多样化的产品组合指导患者护理，并支持我们不断增长的客户群。”

'We are excited to unite with the Advanced Instruments team,' said Mr. Manganaro. 'Our companies share similar values and objectives including a vision for sustained innovation, a strong commitment to the end markets we respectively serve and above all a strong connection to improving patient care globally.

“我们很高兴能与Advanced Instruments团队联合，”Manganaro先生说道。“我们的公司拥有相似的价值观和目标，包括对持续创新的愿景、对我们各自服务的终端市场的坚定承诺，以及最重要的是，对改善全球患者护理的强烈使命感。”

Bringing together our strong teams, focus on innovation and dedication to the customer will strengthen our combined companies and support a bright future for Nova Biomedical.'.

“将我们强大的团队、对创新的关注和对客户的奉献精神结合在一起，将加强我们合并后的公司，并为Nova Biomedical的光明未来提供支持。”

'Growing our platform companies within Patricia Industries is a key priority for us, and we are excited to accelerate Advanced Instruments' growth journey with the acquisition of Nova Biomedical, whose talented team we welcome to the Patricia Industries family,' said Yuriy Prilutskiy, Co-Head of Patricia Industries, a part of Investor AB and owner of Advanced Instruments.

“在 Patricia Industries 内部发展我们的平台公司是我们的关键优先事项，我们很高兴通过收购 Nova Biomedical 来加速 Advanced Instruments 的增长旅程，我们欢迎 Nova Biomedical 的优秀团队加入 Patricia Industries 大家庭，”Investor AB 旗下 Patricia Industries 联合主管、Advanced Instruments 所有者 Yuriy Prilutskiy 表示。

'The combined business will be well-positioned to bring innovative technologies to customers across the clinical and bioprocessing markets, enable patients globally to receive better healthcare, and deliver long-term profitable growth – all of which align with our purpose of creating value for people and society by building strong and sustainable businesses.'.

“合并后的业务将能够很好地为临床和生物处理市场的客户带来创新技术，使全球患者获得更好的医疗保健，并实现长期盈利增长——所有这些都与我们通过建立强大且可持续发展的业务为人类和社会创造价值的目标相一致。”

Closing is subject to regulatory approval and is expected during the third quarter of 2025.

交易的完成取决于监管机构的批准，预计将在2025年第三季度完成。

Advanced Instruments was represented by UBS Investment Bank (financial advisor), Simpson Thacher & Bartlett LLP (legal advisor) and Cooley LLP (legal advisor).

Advanced Instruments 由瑞银投资银行（财务顾问）、辛普森·塔切尔·巴特利特律师事务所（法律顾问）和科利律师事务所（法律顾问）代表。

Nova Biomedical was represented by Jefferies (financial advisor) and

Nova Biomedical 由 Jefferies（财务顾问）代表

David Polk

大卫·波尔克

& Wardwell LLP (legal advisor).

&Wardwell LLP（法律顾问）。

For Further Information

更多信息

：

Advanced Instruments

高级仪器

Contact:

联系人：

Lisa Fahey

丽莎·费伊

603-438-9080

About Advanced Instruments

关于先进仪器

Advanced Instruments is a global provider of scientific and analytical instruments for the biotechnology, clinical, and food and beverage industries. For more than 70 years, the company's innovations have helped organizations improve quality of results, achieve reliable outcomes, and increase workplace productivity.

先进仪器公司是为生物技术、临床、食品和饮料行业提供科学和分析仪器的全球供应商。七十多年来，该公司的创新帮助各组织提高了结果的质量、获得了可靠的成果并提升了工作场所的生产力。

Advanced Instruments has a diverse portfolio of products, including freezing point osmometers, technologies for cell line development, liquid handling verification instrumentation, cerebrospinal fluid cell counters, anaerobic jar systems, and testing standards and controls. Advanced Instruments is based in .

Advanced Instruments 拥有多样化的产品组合，包括冰点渗透压仪、细胞系开发技术、液体处理验证仪器、脑脊液细胞计数器、厌氧罐系统以及测试标准和对照品。Advanced Instruments 总部位于。

Norwood, Massachusetts

诺伍德，马萨诸塞州

and is majority owned by Patricia Industries. For more information, visit

并且主要由 Patricia Industries 拥有。欲了解更多信息，请访问

www.aicompanies.com

。

About Nova Biomedical

关于Nova生物医学

Nova Biomedical is a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The company's innovative products are used in over 100 countries by leading biopharmaceutical companies and hospitals. Nova's clinical products provide point-of-care analysis and monitoring of critical analytes including blood gases and glucose used to diagnose and monitor patients in hospital settings.

Nova Biomedical 是一家为生物制药和临床市场提供分析仪器和耗材的全球供应商。该公司创新的产品被领先的生物制药公司和医院在超过100个国家使用。Nova 的临床产品提供关键分析物的即时检测和监测，包括在医院环境中用于诊断和监测患者的血气和血糖。

Nova's biopharmaceutical products provide mission-critical analytics for research laboratories and drug manufacturing facilities, accelerating and improving the drug development process and product quality. Nova is headquartered in .

Nova的生物制药产品为研究实验室和药物生产设施提供关键任务分析，加速并改善药物开发过程和产品质量。Nova总部位于。

Waltham, Massachusetts

马萨诸塞州沃尔瑟姆

and has approximately 1,600 employees.

并拥有大约1600名员工。

www.novabiomedical.com

About Patricia Industries

关于帕特里夏工业

Patricia Industries, a part of Investor AB, makes control investments in best-in-class companies with strong market positions, brands and corporate cultures within industries positioned for secular growth. Our ambition is to be the sole owner of our companies, together with strong management teams and boards.

Patricia Industries是Investor AB的一部分，专注于对在具有长期增长潜力的行业中拥有强大市场地位、品牌和企业文化的优秀公司进行控股投资。我们的目标是与强大的管理团队和董事会一起成为我们公司的唯一股东。

We invest with an indefinite holding period and focus on building durable value and capturing organic and non-organic growth opportunities. For more information, visit .

我们投资的持有期是无限期的，专注于打造持久价值，并把握有机和非有机的增长机会。欲了解更多信息，请访问。

www.patriciaindustries.com

。

About Investor AB

关于 Investor AB

Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board participation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class.

投资者公司由瓦伦堡家族于1916年创立，是全球高质量企业的积极参与型所有者。我们秉持长期投资的视角。通过董事会参与、行业经验、我们的网络以及财务实力，我们持续支持旗下企业保持或成为行业领先者。

For more information, visit .

如需更多信息，请访问。

www.investorab.com

。

SOURCE Advanced Instruments, LLC

来源：Advanced Instruments, LLC

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM？

440k+